| Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update | 08/13 06:00 | globenewswire.com |
| Gyre Therapeutics to Present at Sidoti Virtual Investor Conference | 08/09 07:00 | globenewswire.com |
| Gyre Therapeutics Announces China's NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia | 07/02 16:05 | globenewswire.com |
| Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology | 06/18 16:05 | globenewswire.com |
| Gyre Pharmaceuticals Receives IND Approval from China's NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension | 05/30 16:05 | globenewswire.com |
| Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes | 05/28 16:05 | globenewswire.com |
| Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | 05/09 16:10 | globenewswire.com |
| The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks | 04/01 08:00 | investors.com |
| Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update | 03/26 06:00 | globenewswire.com |
| Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum | 03/21 07:00 | globenewswire.com |